Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05900570 · ClinicalTrials.gov registry record · NA
Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure
A NA study of Stress Urinary Incontinence, sponsored by Corewell Health East.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05900570: Recruiting NA study of Stress Urinary Incontinence, sponsored by Corewell Health East.
NCT05900570 is a NA study of Stress Urinary Incontinence that is actively recruiting participants, run by Corewell Health East. The registered enrollment target is 20 participants, below the 162-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05900570, a NA study of Stress Urinary Incontinence, is actively recruiting participants, sponsored by Corewell Health East.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this early feasibility prospective study is to gain initial understanding of the effect of acute peri-urethral neurostimulation on the perineal nerves on intra-urethral pressure.
Primary Outcome
Measurement of the change in intra-urethral pressure with peri-urethral neurostimulation compared to intra-urethral pressure with no stimulation.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Urodynamic testing with and without pudendal nerve stimulation
Study Locations (1)
Michigan
- Corewell Health William Beaumont University Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT05900570 shows while recruiting
NCT05900570 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 162-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Urodynamic testing with and without pudendal nerve stimulation is the first listed.
NCT05900570 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05900570 about?
NCT05900570 is a clinical study titled "Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure". The purpose of this early feasibility prospective study is to gain initial understanding of the effect of acute peri-urethral neurostimulation on the perineal nerves on intra-urethral pressure.
What is the current status of trial NCT05900570?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-02-26. Estimated completion is 2027-01.
What conditions does trial NCT05900570 study?
This clinical trial studies the following conditions: Stress Urinary Incontinence.
What interventions are being tested in trial NCT05900570?
The interventions under investigation include: Urodynamic testing with and without pudendal nerve stimulation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05900570?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05900570 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05900570's enrollment target sits among peer trials
20 35th of 35 the lowest of 35 other Stress Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ProACT Post-Approval Study
RECRUITING · NA
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.
RECRUITING · NA
-
Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery
RECRUITING · NA
-
Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy
RECRUITING · NA
-
BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI